Group items tagged

UTI stands for urinary tract infection.Urinary tract infections (UTIs) are the second most common reason people visit their doctors. While both men and women get UTIs, women are more prone to them. The urinary tract consists of: Kidneys, Uterus, ...

UTI stands for urinary tract infection.Urinary tract infections (UTIs) are the second most common reason people visit their doctors. While both men and women get UTIs, women are more prone to them. The urinary tract consists of: Kidneys, Uterus, ...

Urinary tract infection is very common condition ,specially effecting females.But it also occurs in males.It is more common in women of reproductive age group,specially in sexually active women.

Local pharmacists in England can now evaluate and provide treatment for patients with uncomplicated urinary tract infections (UTIs) in women under the age of 65, without the need for a GP appointment. The 'ByeByeUTI' scheme has been expanded across the country, following a successful pilot across North East and North Cumbria. More than 30,000 women have been treated for uncomplicated urinary tract infections at local pharmacies since the pilot scheme was launched in July 2022 as part of the NHS and government's primary care access recovery plan, according to NHS England. The expansion of pharmacy services not only enhances patients' access to care but also frees up tens of thousands of GP appointments at the same time. Dr Faisel Baig, Medical Director for Primary Care, NHS England North East and Yorkshire, said that the rollout of this service across the whole region will enable many more women to receive "faster and easier" access to advice and treatment.

The menopause is a natural aging process, whereby a woman's oestrogen level drops thus disrupting periods until they eventually stop. A woman is said to be in the menopause when her periods have stopped for 12 months. The age when this usually occurs is between 45-55 but symptoms can begin prior to this. Symptoms vary and not all women experience them all. They include hot flushes, vaginal dryness, joint and muscle pain, insomnia, reduced libido, urinary problems such as bladder weakness or Urinary Tract Infections (UTIs), but this list is not exhaustive. Up to a third of women declare that the menopause affects their quality of life. It is obvious that such physical changes can have an effect on ones well-being. Women going through the menopause are at increased risk of developing depression, low self-esteem and problems with concentration (often called brain fog). There are lots of misconceptions in the public and workplace around menopause as it is a little discussed topic. Did you know 45 per cent of women feel their menopause symptoms have had a negative impact on their work and 47 per cent of women have said that they won't tell their employer if they need to take a day-off from work because of menopausal symptoms? So, with women making up nearly half of the UKs workforce, have you thought about what support your workplace offers for you? And if you are an employer, what could you be doing to support your colleagues who need help during this time?

Tribulus terrestris is a rejuvenating tonic for the genitourinary system. A cooling and nourishing herb, Tribulus terrestris soothes the membranes of the urinary tract while promoting the healthy flow of urine. Tribulus terrestris is used in ...

Tribulus terrestris is a rejuvenating tonic for the genitourinary system. A cooling and nourishing herb, Tribulus terrestris soothes the membranes of the urinary tract while promoting the healthy flow of urine. Tribulus terrestris is used in ...

Urinary Tract Infection or UTI is commonly found in most people. It may be due to improper hygiene or due to some other source of infection.

Wales has begun the rolled-out of a community pharmacy prescribing service as part of reforms agreed by the Welsh health minister last December. Eluned Morgan approved wide-ranging changes following re-negotiation of the Community Pharmacy Contractual Framework with Community Pharmacy Wales, the representative body for community pharmacies in Wales. The roll out will allow appropriately trained community pharmacists to treat an extended range of conditions that currently require people to visit their GP. Initially pharmacist prescribers will be able to prescribe medicines, including antibiotics for acute illnesses like urinary tract and upper respiratory tract infections, and also prescribe routine contraception. The first of its kind in the UK, the service is being rolled out progressively across Wales, building on local schemes which are already in place.

Divya Chandraprabha Vati is considered drug of choice of all kinds of problems in the body for both men and women. It especially works on reproductive tract.

Get basic information about bladder infections from the medical experts at Gonzaba Urgent Care. Our medical staff at Gonzaba Urgent Care is dedicated to provide you the best care for your medical needs. For more information about Urinary Tract and/or bladder infections, please contact Gonzaba Urgent Care (210)921-6600.

Amoxil or Amoxicillin is an antibiotic in the class of drugs called penicillins. It fights bacteria in the body. Amoxicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, ear infections, bronchitis, urinary tract infections, gonorrhea, and infections of the skin. Amoxicillin may also be used for purposes other than those listed in this medication guide.

While travelling using public restrooms or outside of your home should not be worry now. Spraying Sanitizer on toilet seats ensure the protection against disease like Urinary Tract infection & others diseases.

The NHS plans to train hundreds of pharmacy staff, expanding their ability to provide advanced clinical services and assume wider roles in dispensing medicines. With a targeted launch in September, up to 840 pharmacy technicians can join in the training programme. The online modules will cover consultation skills, therapeutics, clinical decision-making, assessment skills, and service improvement. "Community pharmacies are pivotal in local communities, and this novel training scheme empowers them to extend their service offerings to a wider patient base," said Health Minister Neil O'Brien. "Through our investment in the workforce, we're bolstering the implementation of the Pharmacy First initiative with £645 million, ensuring patients have access to expert assistance for various common ailments, including urinary tract infections and earaches." NHS said the training will offer flexibility to align with the working schedules and prior experience of community pharmacy technicians. It will combine independent online e-course study, educational supervision, and clinical skills training. Facilitated workshops will concentrate on enhancing clinical assessment skills and applying knowledge and skills through case studies, practice activities, and group discussions.

Northern Ireland's chief pharmaceutical officer paid a visit to a community pharmacy in Belfast on Monday (November 7) - marking the end of this year's Ask Your Pharmacist week, an annual public awareness campaign launched by the National Pharmacy Association. Cathy Harrison interacted with patients and staff in the pharmacy before recording a video to promote NI's 'Pharmacy First' service in which she described community pharmacies as "one of the front doors to the health service" with over 500 outlets located across the country. "In our community pharmacies you can always rely on friendly staff, medicines expertise, and walk-in access to face-to-face advice," she said. First launched in Scotland, the NHS Pharmacy First service enables patients to have a consultation with a pharmacist for advice on minor ailments. Ms Harrison also drew attention to community pharmacy's role in cancer awareness and helping people to quit smoking, as well as managing patients with urinary tract infections, in addition to playing their part in delivering Covid-19 and flu vaccinations.

As part of a new blueprint for primary care, the government today (May 9) announced an investment of £645 million over two years to expand community pharmacy services in England. In a statement, NHS England said: "For the first time ever, patients who need prescription medication will be able to get it directly from a pharmacy, without a GP appointment, for seven common conditions including earache, sore throat, or urinary tract infections." Prime minister Rishi Sunak hopes that the measures will help end the "all-too stressful wait on the end of the phone for patients" by freeing up 15 million slots at doctors' surgeries over the next two years. "We will end the 8am rush and expand the services offered by pharmacies, meaning patients can get their medication quickly and easily," he said Almost half a million women will no longer need to speak to a practice nurse or GP to access oral contraception and will instead be able to pop into their local pharmacy for it, according to the government announcement. Blood checks for people suffering from moderate risk of heart attack or stroke conducted in community pharmacies will more than double from 900,000 last year to 2.5 million next year. NHS chief executive Amanda Pritchard said the "ambitious package" would help transform how care is provided within the health service "with pharmacies playing a central role in managing the nation's health including providing lifesaving checks and medication for common conditions for the first time.

This Pharmacy First Common Ailments service will help patients seek treatment for seven common conditions directly from a pharmacy without the need for a GP appointment or prescription. Launching on 31 January next year although it is subject to IT being ready, the service will cover ailments including "sinusitis, sore throat, earache, infected insect bites, impetigo, shingles, and uncomplicated urinary tract infections (UTIs)" in women. People with symptoms of the above seven conditions will be supplied with a prescription-only treatment under a Patient Group Direction (PGD). Patients seeking assistance at the pharmacy, whether walk-in or referred by NHS 111, GPs, or other sources, can receive consultations. The new service includes self-referring patients plus referrals, and the Community Pharmacist Consultation Service (CPCS) will also be a part of it.

Acknowledging the ongoing challenges in delivering the required IT systems for the scheduled launch of the Pharmacy First service on January 31, NHS England reported progress in fulfilling 'many' commitments outlined in its plan to enhance primary care access during a board meeting on Thursday. However, it noted that the digital infrastructure supporting Pharmacy First, included in the £645 million fresh funding for community pharmacy, will require additional time for implementation. "Delivery remains challenging due to changes needed in digital infrastructure, and we are working with suppliers to support January implementation," NHSE said. "A public campaign is planned for 2024." The Pharmacy First service allows pharmacists to supply prescription-only medicines for seven common health conditions (sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women), eliminating the need for a GP visit. Meanwhile, NHSE is leveraging the widespread accessibility of pharmacies by expanding blood pressure monitoring and introducing direct prescribing of clinically safe oral contraceptives-an initiative that has been well-received.

The Department of Health (DoH) Northern Ireland is reminding the public to think Pharmacy First this winter to stay well and reduce demands on other parts of their health service. Under this new advanced service, a local pharmacy can provide treatment and advice on a range of health conditions including common colds, stomach upsets, ear aches, diarrhoea, head lice, mouth ulcers and thrush. Pharmacies will also directly provide emergency contraception and advice and treatment for uncomplicated Urinary Tract Infections (UTI) for women aged 16 to 64 years without the need for a GP appointment, the department said. Further the public are informed that 42 community pharmacies across the country will be providing a sore throat service this winter, involving advice, testing for infection and treatment, if necessary.

What's valerian root used for? The ancient Greeks and Romans used valerian root to treat: Nausea Gas Heart pulsings Urinary tract infections Insomnia The German tribes believed it could tame the wildest of animals. They also hung it outside their homes to frighten witches and devils. Hertha, a Teutonic witch-goddess, rode a deer crowned with hops and used a stem of valerian as a lash. During the Middle Ages, astrological botanist Nicholas Culpeper simmered valerian root with raisins, licorice, and aniseed. He used the tonic to cure bubonic plague and chest congestion. In 1620, valerian root was carried to North America on the Mayflower. During World War I and II, it was used to reduce stress caused by air attacks. It was also mixed with hops and kava-kava to treat shell-shocked frontline troops. HOW DOES IT WORK? It is a powerful herb used since ancient times to help people relax and fall asleep. Valerian works by acting on the GABA (Gamma-Aminobutyric acid) receptors in your brain to induce relaxation, making it an ideal supplement for those with anxiety or insomnia who want to sleep better at night. The active compounds in valerian plants are called valepotriates, which act as sedatives at low doses and stimulants at higher doses. Valerian Uses & Effectiveness Consuming valerian root extract 300-600 mg by mouth daily appears to improve sleep quality. It is possibly effective for treating Insomnia symptoms. For notice effects, continue its usage for up to 4 weeks. There is welfare in consuming valerian for several other purposes, but it requires more reliable data to say whether it could help. It's generally used in various products containing other soothing herbs, such as hops, passion flowers, and lemon balms.

YouGov polling commissioned by the Pharmaceutical Services Negotiating Committee (PSNC) has revealed that majority of the people responding to the poll said that they would be concern by the pharmacy closure in their locality. The results show the extent of the public backing for a Pharmacy First approach - PSNC has been arguing that a fully-funded service would be beneficial for pharmacies, patients and the wider NHS. The poll witnessed 1,774 adults' participation from England. It showed 68 per cent of people agree that they would find it easier to seek health advice for common conditions, such as skin conditions or indigestion, at a community pharmacy rather than a GP surgery. Only 11 per cent disagreed that this would be easier. While 75 per cent of people agree that they would like to see community pharmacies offering more healthcare services such as treating urinary tract infections or sore throats. Only 6 per cent strongly disagreed with this. When asked how important, if at all, are the services provided by community pharmacies to them, their family, or community, 78 per cent indicted this was very important. Only 14 per cent said this wasn't important. 77 per cent said they would be very concerned if the pharmacy they use most often were to close permanently. Only 19 per cent said they would not be very concerned.

British pharmaceutical giant GSK said on Saturday (April 15) its oral antibiotic drug to treat uncomplicated urinary tract infections (uUTI) in female adults and adolescents met the main goals in late-stage trials. The drug, gepotidacin, in phase III trials, met its primary goals of being on a par or better than nitrofurantoin, the current standard of care for the treatment of uUTIs, the company said. GSK plans to submit results of the trials to the United States Food and Drug Administration for review later in the second quarter. The drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat uUTIs in 20 years, the company said. "Gepotidacin, if approved, will offer a much-needed additional oral treatment option for patients at risk of treatment failure associated with resistance or recurrence of uUTI," Chris Corsico, senior vice president of development at GSK, said.